Range Low Price High Price Comment
30 days $80.52 $93.35 Tuesday, 30th Apr 2024 BMRN stock ended at $80.76. This is 1.67% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 1.58% from a day low at $80.52 to a day high of $81.79.
90 days $80.52 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jan 12, 2023 $110.50 $113.65 $110.01 $113.57 1 723 544
Jan 11, 2023 $111.23 $112.70 $109.14 $111.15 1 699 156
Jan 10, 2023 $107.26 $111.97 $106.99 $111.40 2 864 771
Jan 09, 2023 $109.83 $110.25 $105.95 $107.10 2 526 703
Jan 06, 2023 $108.17 $109.29 $106.90 $108.71 2 205 800
Jan 05, 2023 $107.00 $107.59 $105.77 $106.86 1 794 348
Jan 04, 2023 $103.69 $106.93 $102.26 $106.92 2 710 984
Jan 03, 2023 $103.00 $103.33 $100.52 $100.61 1 025 099
Dec 30, 2022 $101.92 $103.57 $100.95 $103.49 889 346
Dec 29, 2022 $101.87 $103.45 $101.67 $102.44 794 578
Dec 28, 2022 $101.98 $103.10 $101.30 $101.74 904 491
Dec 27, 2022 $104.50 $104.85 $102.03 $102.16 760 711
Dec 23, 2022 $105.01 $105.56 $103.87 $104.34 696 038
Dec 22, 2022 $104.61 $105.70 $103.99 $105.66 1 335 845
Dec 21, 2022 $105.94 $107.08 $104.53 $104.62 1 457 763
Dec 20, 2022 $105.92 $106.75 $105.56 $106.30 997 223
Dec 19, 2022 $108.63 $108.63 $105.81 $106.61 1 225 988
Dec 16, 2022 $107.73 $108.92 $107.13 $108.63 2 537 038
Dec 15, 2022 $108.00 $109.56 $106.81 $108.61 1 614 617
Dec 14, 2022 $106.93 $109.25 $106.51 $108.38 1 672 054
Dec 13, 2022 $107.08 $107.91 $106.55 $107.08 1 765 332
Dec 12, 2022 $102.25 $106.35 $102.25 $106.26 1 856 434
Dec 09, 2022 $104.23 $104.46 $102.28 $102.33 815 513
Dec 08, 2022 $103.99 $104.62 $103.17 $104.39 723 024
Dec 07, 2022 $101.09 $103.94 $101.09 $103.69 1 319 198
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT